Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

08 Nov, EOD - Indian

SENSEX 79486.32 (-0.07)

Nifty 50 24148.2 (-0.21)

Nifty Bank 51561.2 (-0.68)

Nifty IT 42050.15 (0.71)

Nifty Midcap 100 56352 (-1.33)

Nifty Next 50 69774.2 (-1.23)

Nifty Pharma 22542.25 (0.07)

Nifty Smallcap 100 18445.6 (-1.70)

08 Nov, EOD - Global

NIKKEI 225 39500.37 (0.30)

HANG SENG 20728.19 (-1.07)

S&P 6012.5 (-0.05)

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 532989 | NSE Symbol : BAFNAPH | ISIN : INE878I01022 | Industry : Pharmaceuticals |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	152.47	115.35	85.14	71.22	42.47
Sale of Products	150.94	114.05	81.75	67.27	41.39
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	1.53	1.30	3.39	3.95	1.08
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	152.47	115.35	85.14	71.22	42.47
Other Income	3.52	3.27	1.70	0.75	0.26
Total Revenue	155.99	118.62	86.84	71.97	42.73
Changes in Inventories	-4.85	-2.91	-1.77	2.95	-3.24
Cost of Material Consumed	79.01	59.57	41.70	33.58	23.20
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	12.57	6.41	0.00	0.00	0.02
Employee Benefits	19.03	15.87	14.65	11.98	10.25
Total Other Expenses	35.60	20.70	18.60	12.41	11.01
Manufacturing / Operating Expenses	20.42	13.82	11.53	9.55	7.24
Administrative and Selling Expenses	14.12	5.55	7.03	2.78	3.65
Other Expenses	1.06	1.33	0.04	0.07	0.12
Finance Costs	2.29	2.04	0.79	0.74	0.10
Depreciation and Amortization	5.00	5.33	5.49	4.48	3.27
Total Expenses	148.64	107.01	79.47	66.14	44.61
Profit Before Exceptional Items and Tax	7.35	11.62	7.37	5.83	-1.88
Exceptional Items Before Tax	0.00	0.00	-2.16	0.00	0.00
Profit Before Extraordinary Items and Tax	7.35	11.62	5.22	5.83	-1.88
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	7.35	11.62	5.22	5.83	-1.88
Taxation	0.00	0.28	0.00	0.00	0.00
Current Tax	0.00	0.00	0.00	0.00	0.00
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.28	0.00	0.00	0.00
Profit After Tax	7.35	11.34	5.22	5.83	-1.88
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	-23.33
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	7.35	11.34	5.22	5.83	-25.20
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	7.35	11.34	5.22	5.83	-25.20
Earning Per Share - Basic	3.11	4.79	2.19	2.46	-106.54
Earning Per Share - Diluted	3.11	4.79	2.19	2.46	-106.54

LOGIN HERE

LOGIN HERE

Bafna Pharmaceuticals Ltd

Profit and Loss